CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) $ in Thousands	Preferred stock	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Total
Balance at beginning of period at Dec. 31, 2023		$ 14	$ 112,565	$ (98,150)	$ 14,429
Balance at beginning of period (in shares) at Dec. 31, 2023	47	1,420,125
Increase (Decrease) in Stockholders' Equity
Net loss				(2,079)	(2,079)
Issuance of common stock in connection with at the market offering, net of issuance costs			67		67
Issuance of common stock in connection with at the market offering, net of issuance costs (in shares)		10,167
Stock-based compensation			357		357
Balance at end of period at Mar. 31, 2024		$ 14	112,989	(100,229)	12,774
Balance at end of period (in shares) at Mar. 31, 2024	47	1,430,292
Balance at beginning of period at Dec. 31, 2024		$ 15	114,519	(102,440)	12,094
Balance at beginning of period (in shares) at Dec. 31, 2024	47	1,493,639
Increase (Decrease) in Stockholders' Equity
Net loss				(884)	(884)
Issuance of common stock for consulting services			65		65
Issuance of common stock for consulting services (in shares)		10,673
Stock-based compensation			423		423
Balance at end of period at Mar. 31, 2025		$ 15	$ 115,007	$ (103,324)	$ 11,698
Balance at end of period (in shares) at Mar. 31, 2025	47	1,504,312